The Importance of Electrical Stimulation as a Treatment for Urinary Incontinence in Patients Prostatectomy

N/ACompletedNCT02073721

Universidade Gama Filho34 enrolled

Overview

The use of electrical stimulation to reduce urinary incontinence in men undergoing prostatectomy exercises of the pelvic floor muscles (MAPs)

The study will be an experiment with active control, randomized, double-blind, parallel intervention. After met the eligibility criteria of the patients will be randomly allocated into two groups: Group exercises MAPs (GEX), which is the active control group and electrostimulation + exercises MAPs (GEEX).

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

Urinary Incontinence

Interventions

electrostimulation with exercises MAPsOTHER

this group will make the electrostimulation with exercises of the pelvic floor muscles with a focus on strengthening the pelvic floor muscles.the frequency will be 20 sessions, 2 times per week, lasting 30 minutes.

exercises MAPsOTHER

This group will focus exercises of the pelvic floor muscles with strengthening the muscles of the pelvic floor. the frequency will be 20 sessions, 2 times per week, lasting 30 minutes.

Eligibility

Sex: MALEMin age: 50 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * patients with urinary sphincter deficiency resulting from a radical prostatectomy surgery * sent by urologists the same hospital where the experiment will take place * having the maximum time six months after surgery * to use 2 to 5 disposable protective per day Exclusion Criteria: * Symptoms of urinary tract infection * symptoms of lower urinary tract obstruction * anal fistula * metallic implant in the body * transurethral resection of prostate * radiation therapy * non-enforcement of the proposed treatment.

Locations (1)

Federal Hospital Servants of the State of Rio de Janeiro

Rio de Janeiro, RJ/Rio de Janeiro, Brazil

Outcomes

Primary Outcomes

urinary incontinence

Time frame: august/2013 to December/2013 (4 months)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.